• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 作为癌症治疗的潜在分子

MicroRNA as a Potential Therapeutic Molecule in Cancer.

机构信息

Centre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University, Ul. Wilenska 4, 87-100 Torun, Poland.

Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Ul. Lwowska 1, 87-100 Torun, Poland.

出版信息

Cells. 2022 Mar 16;11(6):1008. doi: 10.3390/cells11061008.

DOI:10.3390/cells11061008
PMID:35326459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8947269/
Abstract

Small noncoding RNAs, as post-translational regulators of many target genes, are not only markers of neoplastic disease initiation and progression, but also markers of response to anticancer therapy. Hundreds of miRNAs have been identified as biomarkers of drug resistance, and many have demonstrated the potential to sensitize cancer cells to therapy. Their properties of modulating the response of cells to therapy have made them a promising target for overcoming drug resistance. Several methods have been developed for the delivery of miRNAs to cancer cells, including introducing synthetic miRNA mimics, DNA plasmids containing miRNAs, and small molecules that epigenetically alter endogenous miRNA expression. The results of studies in animal models and preclinical studies for solid cancers and hematological malignancies have confirmed the effectiveness of treatment protocols using microRNA. Nevertheless, the use of miRNAs in anticancer therapy is not without limitations, including the development of a stable nanoconstruct, delivery method choices, and biodistribution. The aim of this review was to summarize the role of miRNAs in cancer treatment and to present new therapeutic concepts for these molecules. Supporting anticancer therapy with microRNA molecules has been verified in numerous clinical trials, which shows great potential in the treatment of cancer.

摘要

小非编码 RNA 作为许多靶基因的翻译后调控因子,不仅是肿瘤疾病发生和进展的标志物,也是抗癌治疗反应的标志物。已经鉴定出数百种 miRNA 作为耐药性的生物标志物,许多 miRNA 已经证明了使癌细胞对治疗敏感的潜力。它们调节细胞对治疗反应的特性使它们成为克服耐药性的有前途的靶标。已经开发了几种将 miRNA 递送至癌细胞的方法,包括引入合成 miRNA 模拟物、包含 miRNA 的 DNA 质粒和表观遗传改变内源性 miRNA 表达的小分子。针对实体瘤和血液恶性肿瘤的动物模型和临床前研究的结果证实了使用 microRNA 的治疗方案的有效性。然而,miRNA 在抗癌治疗中的应用并非没有局限性,包括稳定的纳米结构的开发、递送方法的选择和生物分布。本综述的目的是总结 miRNA 在癌症治疗中的作用,并提出这些分子的新治疗概念。许多临床试验证实了 microRNA 分子对癌症治疗的支持作用,这表明其在癌症治疗方面具有巨大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/8947269/a86d2cd578dd/cells-11-01008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/8947269/a86d2cd578dd/cells-11-01008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/8947269/a86d2cd578dd/cells-11-01008-g001.jpg

相似文献

1
MicroRNA as a Potential Therapeutic Molecule in Cancer.微小 RNA 作为癌症治疗的潜在分子
Cells. 2022 Mar 16;11(6):1008. doi: 10.3390/cells11061008.
2
MicroRNA: Promising Roles in Cancer Therapy.微小 RNA:癌症治疗中的大有可为的角色。
Curr Pharm Biotechnol. 2020;21(12):1186-1203. doi: 10.2174/1389201021666200420101613.
3
MicroRNA and Metastasis.微小 RNA 与转移。
Adv Cancer Res. 2016;132:165-207. doi: 10.1016/bs.acr.2016.07.004. Epub 2016 Aug 9.
4
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).靶向致癌 miRNA 并模拟肿瘤抑制 miRNA:肿瘤 miRNA 治疗策略开发的新趋势(综述)。
Int J Oncol. 2016 Jul;49(1):5-32. doi: 10.3892/ijo.2016.3503. Epub 2016 May 4.
5
MicroRNA replacement therapy in cancer.癌症的 microRNA 替换疗法。
J Cell Physiol. 2019 Aug;234(8):12369-12384. doi: 10.1002/jcp.28058. Epub 2019 Jan 3.
6
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
7
Treating cancer with microRNA replacement therapy: A literature review.用 microRNA 替换疗法治疗癌症:文献综述。
J Cell Physiol. 2018 Aug;233(8):5574-5588. doi: 10.1002/jcp.26514. Epub 2018 Mar 9.
8
A step-by-step microRNA guide to cancer development and metastasis.癌症发生和转移的分步 miRNA 指南。
Cell Oncol (Dordr). 2017 Aug;40(4):303-339. doi: 10.1007/s13402-017-0341-9. Epub 2017 Jul 26.
9
MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.微小RNA作为结直肠癌治疗干预的潜在药物靶点。
Expert Opin Ther Targets. 2015;19(12):1705-23. doi: 10.1517/14728222.2015.1069816. Epub 2015 Jul 18.
10
Small molecules targeting microRNA for cancer therapy: Promises and obstacles.靶向微小RNA用于癌症治疗的小分子:前景与障碍。
J Control Release. 2015 Dec 10;219:237-247. doi: 10.1016/j.jconrel.2015.08.011. Epub 2015 Aug 6.

引用本文的文献

1
Daily Profile of miRNAs in the Rat Colon and In Silico Analysis of Their Possible Relationship to Colorectal Cancer.大鼠结肠中miRNA的每日表达谱及其与结直肠癌可能关系的计算机分析
Biomedicines. 2025 Jul 31;13(8):1865. doi: 10.3390/biomedicines13081865.
2
Endocrine-disrupting chemicals (EDCs) and epigenetic regulation in embryonic development: Mechanisms, impacts, and emerging trends.内分泌干扰化学物质(EDCs)与胚胎发育中的表观遗传调控:作用机制、影响及新趋势
Toxicol Rep. 2024 Dec 27;14:101885. doi: 10.1016/j.toxrep.2024.101885. eCollection 2025 Jun.
3
Exosomal delivery of non-coding RNAs: a pathway to apoptosis regulation in lung cancer.

本文引用的文献

1
MicroRNA and liver cancer.微小RNA与肝癌
Cancer Drug Resist. 2020 Apr 17;3(3):385-400. doi: 10.20517/cdr.2019.110. eCollection 2020.
2
miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene.微小RNA-200c通过下调多药耐药基因1增加乳腺癌细胞对阿霉素的敏感性。
Exp Mol Pathol. 2022 Apr;125:104753. doi: 10.1016/j.yexmp.2022.104753. Epub 2022 Feb 27.
3
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.miR-99b-5p、miR-380-3p 和 miR-485-3p 是高危神经母细胞瘤中新型的化疗增敏 miRNA。
外泌体介导的非编码RNA传递:肺癌细胞凋亡调控途径
Med Oncol. 2025 Jul 1;42(8):307. doi: 10.1007/s12032-025-02852-9.
4
MiR 329/449 Suppresses Cell Proliferation, Migration and Synergistically Sensitizes GBM to TMZ by Inhibiting Src/FAK, NF-kB, and Cyclin D1 Activity.微小RNA 329/449通过抑制Src/黏着斑激酶、核因子κB和细胞周期蛋白D1的活性来抑制细胞增殖、迁移,并协同增强胶质母细胞瘤对替莫唑胺的敏感性。
Int J Mol Sci. 2025 Jun 10;26(12):5533. doi: 10.3390/ijms26125533.
5
MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1.微小RNA-142-3p通过靶向YES1和TWF1克服肝细胞癌的耐药性。
Int J Mol Sci. 2025 Apr 27;26(9):4161. doi: 10.3390/ijms26094161.
6
miRNAs from Zebrafish Embryo Extracts Inhibit Breast Cancer Invasiveness and Migration by Modulating miR-218-5p/PI3K Pathway.来自斑马鱼胚胎提取物的微小RNA通过调节miR-218-5p/PI3K信号通路抑制乳腺癌的侵袭和迁移。
Int J Mol Sci. 2025 Apr 17;26(8):3812. doi: 10.3390/ijms26083812.
7
Association of genetic variants in MIR17HG and in the promoter of MIR17HG with susceptibility to cancer in Chinese Han population: a systematic review and meta-analysis.MIR17HG基因变异及MIR17HG启动子与中国汉族人群癌症易感性的关联:一项系统评价和荟萃分析
BMC Cancer. 2025 Apr 7;25(1):631. doi: 10.1186/s12885-025-14018-x.
8
MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p/PI3K/Akt signaling pathway.MTFR2通过miR-132-3p/PI3K/Akt信号通路促进子宫内膜癌细胞的增殖和生长。
Front Med (Lausanne). 2025 Mar 10;11:1505071. doi: 10.3389/fmed.2024.1505071. eCollection 2024.
9
MiRNAs: main players of cancer drug resistance target ABC transporters.微小RNA:癌症耐药性的主要作用靶点是ABC转运蛋白。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 14. doi: 10.1007/s00210-024-03719-y.
10
Multilevel Mechanisms of Cancer Drug Resistance.癌症药物耐药性的多层次机制。
Int J Mol Sci. 2024 Nov 19;25(22):12402. doi: 10.3390/ijms252212402.
Mol Ther. 2022 Mar 2;30(3):1119-1134. doi: 10.1016/j.ymthe.2022.01.004. Epub 2022 Jan 5.
4
Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer.靶向致癌性miR-181a-2-3p可抑制胃癌生长并克服顺铂耐药性
Cancer Manag Res. 2021 Nov 16;13:8599-8609. doi: 10.2147/CMAR.S332713. eCollection 2021.
5
Lactate induces aberration in the miR-30a-DBF4 axis to promote the development of gastric cancer and weakens the sensitivity to 5-Fu.乳酸诱导miR-30a-DBF4轴异常,以促进胃癌发展并削弱对5-氟尿嘧啶的敏感性。
Cancer Cell Int. 2021 Nov 10;21(1):602. doi: 10.1186/s12935-021-02291-2.
6
MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.miR-16-5p 通过靶向 ANLN 抑制乳腺癌增殖。
BMC Cancer. 2021 Nov 7;21(1):1188. doi: 10.1186/s12885-021-08914-1.
7
Decreased expression of miR-3135b reduces sensitivity to 5-fluorouracil in colorectal cancer by direct repression of PIM1.miR-3135b表达降低通过直接抑制PIM1降低结直肠癌对5-氟尿嘧啶的敏感性。
Exp Ther Med. 2021 Oct;22(4):1151. doi: 10.3892/etm.2021.10585. Epub 2021 Aug 10.
8
Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment.长链非编码 RNA HAND2-AS1/miR-106a/PTEN 轴使顺铂耐药的卵巢细胞重新对顺铂治疗敏感。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12402. Epub 2021 Sep 3.
9
Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment.载多西他赛和 miRNA-34a 的叶酸靶向杂化脂质聚合物纳米复合物用于乳腺癌治疗。
Mater Sci Eng C Mater Biol Appl. 2021 Sep;128:112305. doi: 10.1016/j.msec.2021.112305. Epub 2021 Jul 10.
10
Knockdown of Myeloid Cell Leukemia-1 by MicroRNA-101 Increases Sensitivity of A549 Lung Cancer Cells to Etoposide.miR-101 通过下调髓样细胞白血病-1 增加 A549 肺癌细胞对依托泊苷的敏感性。
Iran J Med Sci. 2021 Jul;46(4):298-307. doi: 10.30476/ijms.2020.83173.1203.